Literature DB >> 16691637

Co-expression of sCD40LIg and CTLA4Ig mediated by adenovirus prolonged mouse skin allograft survival.

Zhao-lun Li1, Pu-xun Tian, Wu-jun Xue, Jun Wu.   

Abstract

OBJECTIVE: To investigate the role of simultaneous blockade of CD40/CD40L and B7/CD28 pathways in the immune tolerance via co-expression of sCD40LIg and CTLA4Ig mediated by replication-defective adenovirus.
METHODS: Ad-sCD40LIg-IRES(2)-CTLA4Ig, replication-defective adenovirus co-expressing sCD40LIg and CTLA4Ig, was constructed and identified. The co-expression of sCD40LIg and CTLA4Ig was evaluated with confocal laser scanning microscope and Western blotting. Skin transplantations of C57BL/6 to BALB/c mice were performed. PBS, Ad-Shuttle-CMV and Ad-sCD40LIg-IRES(2)-CTLA4Ig were administered. Skin graft survival was monitored and the mRNA expression of both genes was evaluated in the skin allografts.
RESULTS: Ad-sCD40LIg-IRES(2)-CTLA4Ig was constructed successfully and identified. The co-expression of sCD40LIg and CTLA4Ig was identified with confocal laser scanning microscopy and Western blotting. Compared to the skin graft mean survival time (MST) of non-treated group ((5.75+/-0.71) d) or Ad-Shuttle-CMV-treated group ((5.50+/-0.53) d), the skin graft MST was dramatically prolonged in the Ad-sCD40LIg-IRES(2)-CTLA4Ig-treated group ((16.38+/-1.19) d, P<0.001). The mRNA expression of both genes was detected.
CONCLUSION: Ad-sCD40LIg-IRES(2)-CTLA4Ig, a replication-defective adenovirus carrying genes encoding sCD40LIg and CTLA4Ig, was constructed. Simultaneous blockade of CD40/CD40L and B7/CD28 costimulatory pathway mediated by replication-defective adenovirus significantly prolonged skin allograft survival in mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16691637      PMCID: PMC1473999          DOI: 10.1631/jzus.2006.B0436

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  57 in total

1.  An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.

Authors:  A I Kuzmin; O Galenko; R C Eisensmith
Journal:  Mol Ther       Date:  2001-03       Impact factor: 11.454

2.  A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death.

Authors:  A W Kuss; M Knödel; F Berberich-Siebelt; D Lindemann; A Schimpl; I Berberich
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

3.  Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions.

Authors:  N Chirmule; S E Raper; L Burkly; D Thomas; J Tazelaar; J V Hughes; J M Wilson
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.

Authors:  E Akalin; A Chandraker; M E Russell; L A Turka; W W Hancock; M H Sayegh
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

5.  Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.

Authors:  Z L Jiang; D Reay; F Kreppel; A Gambotto; E Feingold; S Kochanek; S A McCarthy; P R Clemens
Journal:  Mol Ther       Date:  2001-06       Impact factor: 11.454

6.  Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.

Authors:  J K Whitmire; K Murali-Krishna; J Altman; R Ahmed
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

7.  CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation.

Authors:  N Sakata; H Kawasome; N Terada; G L Johnson; E W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2000-03       Impact factor: 10.793

8.  Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.

Authors:  S O Andreasen; J E Christensen; O Marker; A R Thomsen
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

9.  The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.

Authors:  B Reddy; S Gupta; Y Chuzhin; A M Kalergis; L Budhai; M Zhang; G Droguett; M S Horwitz; J R Chowdhury; S G Nathenson; A Davidson
Journal:  Transplantation       Date:  2001-03-27       Impact factor: 4.939

10.  Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.

Authors:  M A Kay; L Meuse; A M Gown; P Linsley; D Hollenbaugh; A Aruffo; H D Ochs; C B Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

View more
  1 in total

1.  Cationic liposome-mediated transfection of CD40 ligand gene inhibits hepatic tumor growth of hepatocellular carcinoma in mice.

Authors:  Yong-fang Jiang; Jing Ma; Yan He; Yong-hong Zhang; Yun Xu; Guo-zhong Gong
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.